SNCA and Lewy body dementia: Using this methodology to deliver human α-synuclein in a recombinant adeno-associated viral (AAV) serotype 6 vector (AAV6), we were able to create a novel rat model exhibiting α-synuclein over-expression mainly localized to the cerebral cortices, mimicking primarily cerebral type of Lewy body disease [20].